United States:
Podcast: Susan Tull On Patenting The Future Of Medicine
02 May 2018
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Artificial intelligence, or AI, is rapidly transforming the
world of medicine. AI computers are diagnosing medical conditions
at a rate equal to or better than humans, all while developing
their own code and algorithms to do so. With the rise of AI, there
are new issues of patentability, inventorship, and ownership that
must be addressed. In this podcast, Finnegan partner
Susan Tull discusses current issues surrounding
intellectual property and AI in medicine.
To listen to the podcast, please click
here
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.